MAIA Biotechnology Expands THIO-101 Trial with Winship Enrollment
CHICAGO, June 18, 2026 MAIA Biotechnology, Inc. announced that Winship Cancer Institute of Emory University, Georgia’s only National Cancer...
AI drug discovery artificial intelligence ASCO 2026 Autoimmune Disease Bio-Pharma biologics biopharma Biopharmaceuticals Biotechnology Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology oncology innovation Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory compliance targeted therapy
CHICAGO, June 18, 2026 MAIA Biotechnology, Inc. announced that Winship Cancer Institute of Emory University, Georgia’s only National Cancer...
CHICAGO, USA | December 24, 2025 — MAIA Biotechnology, a clinical-stage biopharmaceutical company focused on targeted immuno-oncology, announced that...
